

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.30670341 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.20527100 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.78354513 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.57628881 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.25238434 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.16108175 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.10760211 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.10760211 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.03664484 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 4.89634414 |
| 11 | detection of bacterium (GO:0016045) | 4.52455273 |
| 12 | regulation of B cell differentiation (GO:0045577) | 4.52210468 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 4.44858711 |
| 14 | detection of other organism (GO:0098543) | 4.43556354 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.38239538 |
| 16 | microglial cell activation (GO:0001774) | 4.32523106 |
| 17 | myeloid cell activation involved in immune response (GO:0002275) | 4.28118856 |
| 18 | response to peptidoglycan (GO:0032494) | 4.16091455 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.13738079 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.13738079 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.13738079 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.13738079 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.13738079 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 4.13738079 |
| 25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.13465620 |
| 26 | neutrophil activation (GO:0042119) | 4.10312808 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.09977276 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 4.07578386 |
| 29 | negative regulation of interleukin-12 production (GO:0032695) | 4.06131968 |
| 30 | response to interleukin-15 (GO:0070672) | 4.03992550 |
| 31 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.90582012 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 3.88920375 |
| 33 | leukocyte aggregation (GO:0070486) | 3.85761358 |
| 34 | leukocyte degranulation (GO:0043299) | 3.85602548 |
| 35 | positive regulation of mast cell activation (GO:0033005) | 3.79264143 |
| 36 | cellular extravasation (GO:0045123) | 3.75425793 |
| 37 | cellular response to interleukin-15 (GO:0071350) | 3.73607822 |
| 38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.71840268 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.69616807 |
| 40 | granulocyte activation (GO:0036230) | 3.67988646 |
| 41 | mast cell activation (GO:0045576) | 3.64438011 |
| 42 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.60871369 |
| 43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.60345820 |
| 44 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.60311714 |
| 45 | positive regulation of mast cell degranulation (GO:0043306) | 3.60311714 |
| 46 | negative thymic T cell selection (GO:0045060) | 3.59448340 |
| 47 | positive T cell selection (GO:0043368) | 3.57141584 |
| 48 | negative T cell selection (GO:0043383) | 3.57003291 |
| 49 | regulation of mast cell activation (GO:0033003) | 3.48574695 |
| 50 | positive thymic T cell selection (GO:0045059) | 3.46761997 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.45286937 |
| 52 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.39343894 |
| 53 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.38702818 |
| 54 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.38702818 |
| 55 | histone H4-K12 acetylation (GO:0043983) | 3.38079098 |
| 56 | mast cell degranulation (GO:0043303) | 3.35434481 |
| 57 | mast cell activation involved in immune response (GO:0002279) | 3.35434481 |
| 58 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34944831 |
| 59 | B cell receptor signaling pathway (GO:0050853) | 3.34371073 |
| 60 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.33467019 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 3.32015703 |
| 62 | regulation of leukocyte degranulation (GO:0043300) | 3.30987712 |
| 63 | T cell selection (GO:0045058) | 3.29093159 |
| 64 | macrophage activation (GO:0042116) | 3.26229683 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.25902775 |
| 66 | B cell mediated immunity (GO:0019724) | 3.23713916 |
| 67 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.22416947 |
| 68 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.22416947 |
| 69 | megakaryocyte development (GO:0035855) | 3.20653056 |
| 70 | positive regulation of granulocyte differentiation (GO:0030854) | 3.18270106 |
| 71 | defense response to protozoan (GO:0042832) | 3.16502633 |
| 72 | T cell migration (GO:0072678) | 3.16278552 |
| 73 | detection of external biotic stimulus (GO:0098581) | 3.16271405 |
| 74 | Peyers patch development (GO:0048541) | 3.15684792 |
| 75 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.15684792 |
| 76 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.11893078 |
| 77 | phagocytosis, engulfment (GO:0006911) | 3.11764176 |
| 78 | response to protozoan (GO:0001562) | 3.09475061 |
| 79 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.07013654 |
| 80 | regulation of antigen processing and presentation (GO:0002577) | 3.07004222 |
| 81 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.02753354 |
| 82 | activated T cell proliferation (GO:0050798) | 3.00619036 |
| 83 | response to host immune response (GO:0052572) | 3.00020514 |
| 84 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.00020514 |
| 85 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.98672539 |
| 86 | respiratory burst (GO:0045730) | 2.98119610 |
| 87 | negative regulation of innate immune response (GO:0045824) | 2.95453470 |
| 88 | autophagic vacuole fusion (GO:0000046) | 2.94311563 |
| 89 | detection of biotic stimulus (GO:0009595) | 2.90988241 |
| 90 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.90642137 |
| 91 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.88852672 |
| 92 | interferon-gamma production (GO:0032609) | 2.88342904 |
| 93 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88083357 |
| 94 | cellular defense response (GO:0006968) | 2.85113803 |
| 95 | positive regulation of type 2 immune response (GO:0002830) | 2.84946182 |
| 96 | mature B cell differentiation involved in immune response (GO:0002313) | 2.84819753 |
| 97 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.78116725 |
| 98 | positive regulation of interleukin-17 production (GO:0032740) | 2.77425244 |
| 99 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.76166441 |
| 100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.74554219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.84068925 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.77604646 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.62637663 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.34335296 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.31837476 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.22761255 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.02816592 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.02185558 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.00691003 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.95123865 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.94585398 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.81768750 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.79860182 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.79253682 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78888762 |
| 16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.72474496 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.70840725 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64489148 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52183740 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.50970677 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.47566743 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.43363484 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41041304 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31213633 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30181914 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.29310087 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 2.28997849 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.28243946 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.26810353 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.24975721 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.18996609 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.09906932 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.04426063 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.04299711 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01525329 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01129721 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99561930 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97196375 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.92101071 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86545671 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79186195 |
| 42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.78250871 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.78035413 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74525052 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.74093078 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.70561845 |
| 47 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65319217 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63139504 |
| 49 | GATA3_26560356_Chip-Seq_TH2_Human | 1.57784927 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.47066628 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46095704 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45969506 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.45873313 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40913059 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38432128 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.37327323 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.36374464 |
| 58 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34594588 |
| 59 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.33938280 |
| 60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33830935 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32401632 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28689986 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27267818 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27045147 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24496571 |
| 66 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24080672 |
| 67 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21784751 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21209446 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19825461 |
| 70 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19666801 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18359276 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17513067 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16846707 |
| 74 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16388737 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15567396 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14996378 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13231072 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11513495 |
| 79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11370003 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08322907 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08083826 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05799398 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05549554 |
| 84 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05495847 |
| 85 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04362956 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03801074 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03362037 |
| 88 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99996345 |
| 89 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95923922 |
| 90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95818255 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95487185 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94957844 |
| 93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94577962 |
| 94 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93223615 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93215843 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.90957931 |
| 97 | P300_27268052_Chip-Seq_Bcells_Human | 0.88019961 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86647310 |
| 99 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86607632 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83884187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.40394430 |
| 2 | MP0003436_decreased_susceptibility_to | 3.71356084 |
| 3 | MP0005671_abnormal_response_to | 3.69123611 |
| 4 | MP0003724_increased_susceptibility_to | 3.60375087 |
| 5 | MP0006082_CNS_inflammation | 3.37701313 |
| 6 | MP0002419_abnormal_innate_immunity | 2.97130816 |
| 7 | MP0009785_altered_susceptibility_to | 2.96807128 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.92304282 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.87657076 |
| 10 | MP0005025_abnormal_response_to | 2.86010662 |
| 11 | MP0000685_abnormal_immune_system | 2.84848797 |
| 12 | MP0001800_abnormal_humoral_immune | 2.74474192 |
| 13 | MP0003303_peritoneal_inflammation | 2.71652988 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.62998468 |
| 15 | MP0001819_abnormal_immune_cell | 2.60907515 |
| 16 | MP0002723_abnormal_immune_serum | 2.59052610 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.58518776 |
| 18 | MP0002396_abnormal_hematopoietic_system | 2.57732507 |
| 19 | MP0001790_abnormal_immune_system | 2.55210529 |
| 20 | MP0005387_immune_system_phenotype | 2.55210529 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.55074153 |
| 22 | MP0009278_abnormal_bone_marrow | 2.52527848 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.39221592 |
| 24 | MP0008260_abnormal_autophagy | 2.37760121 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.27969847 |
| 26 | MP0002398_abnormal_bone_marrow | 2.16275474 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.14273256 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 2.09403382 |
| 29 | MP0001545_abnormal_hematopoietic_system | 2.09403382 |
| 30 | MP0000716_abnormal_immune_system | 2.04042348 |
| 31 | MP0002405_respiratory_system_inflammati | 1.96225395 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 1.91196838 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.90268694 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.82398258 |
| 35 | MP0002722_abnormal_immune_system | 1.80085085 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.79834026 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.77684269 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.66205649 |
| 39 | MP0002429_abnormal_blood_cell | 1.65413216 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.60973619 |
| 41 | MP0002132_abnormal_respiratory_system | 1.57664912 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.47989560 |
| 43 | MP0004947_skin_inflammation | 1.46517154 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.40183861 |
| 45 | MP0008469_abnormal_protein_level | 1.37880231 |
| 46 | MP0003690_abnormal_glial_cell | 1.34745064 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.30871903 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.28031203 |
| 49 | MP0005166_decreased_susceptibility_to | 1.24101904 |
| 50 | MP0009764_decreased_sensitivity_to | 1.22018426 |
| 51 | MP0003866_abnormal_defecation | 1.14621217 |
| 52 | MP0005310_abnormal_salivary_gland | 1.14369481 |
| 53 | MP0004883_abnormal_blood_vessel | 1.11606970 |
| 54 | MP0003075_altered_response_to | 1.10657271 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.07012266 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.04103413 |
| 57 | MP0000858_altered_metastatic_potential | 1.03808651 |
| 58 | MP0001851_eye_inflammation | 1.03755763 |
| 59 | MP0001986_abnormal_taste_sensitivity | 1.02420658 |
| 60 | MP0009840_abnormal_foam_cell | 1.01119660 |
| 61 | MP0009763_increased_sensitivity_to | 0.99568276 |
| 62 | MP0009765_abnormal_xenobiotic_induced | 0.93883851 |
| 63 | MP0003828_pulmonary_edema | 0.92952196 |
| 64 | MP0006054_spinal_hemorrhage | 0.92908073 |
| 65 | MP0001188_hyperpigmentation | 0.91960634 |
| 66 | MP0008004_abnormal_stomach_pH | 0.89030637 |
| 67 | MP0004381_abnormal_hair_follicle | 0.88792081 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 0.87728875 |
| 69 | MP0001853_heart_inflammation | 0.86668049 |
| 70 | MP0002019_abnormal_tumor_incidence | 0.83024387 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.82926138 |
| 72 | MP0000343_altered_response_to | 0.82605249 |
| 73 | MP0001873_stomach_inflammation | 0.81712927 |
| 74 | MP0005390_skeleton_phenotype | 0.81045866 |
| 75 | MP0002166_altered_tumor_susceptibility | 0.80511922 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.80455906 |
| 77 | MP0008873_increased_physiological_sensi | 0.79669891 |
| 78 | MP0005164_abnormal_response_to | 0.78951158 |
| 79 | MP0002006_tumorigenesis | 0.78863913 |
| 80 | MP0003448_altered_tumor_morphology | 0.70843388 |
| 81 | MP0003795_abnormal_bone_structure | 0.70702688 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.68875180 |
| 83 | MP0000490_abnormal_crypts_of | 0.66971548 |
| 84 | MP0001663_abnormal_digestive_system | 0.66132020 |
| 85 | MP0005451_abnormal_body_composition | 0.63402015 |
| 86 | MP0008872_abnormal_physiological_respon | 0.61541645 |
| 87 | MP0000604_amyloidosis | 0.60936802 |
| 88 | MP0005670_abnormal_white_adipose | 0.60703105 |
| 89 | MP0000681_abnormal_thyroid_gland | 0.58667275 |
| 90 | MP0001764_abnormal_homeostasis | 0.57991764 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.57781988 |
| 92 | MP0001915_intracranial_hemorrhage | 0.56284740 |
| 93 | MP0000249_abnormal_blood_vessel | 0.55495833 |
| 94 | MP0005535_abnormal_body_temperature | 0.54858741 |
| 95 | MP0002933_joint_inflammation | 0.54230572 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.49227463 |
| 97 | MP0005084_abnormal_gallbladder_morpholo | 0.48749920 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.47349967 |
| 99 | MP0001765_abnormal_ion_homeostasis | 0.44817177 |
| 100 | MP0004130_abnormal_muscle_cell | 0.41265315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 5.60315095 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.49502511 |
| 3 | Orchitis (HP:0100796) | 5.18403002 |
| 4 | Optic neuritis (HP:0100653) | 4.94243458 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 4.94243458 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.93072575 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.51415551 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.44786995 |
| 9 | Stomatitis (HP:0010280) | 4.44644356 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 4.44039855 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.24895138 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.18335520 |
| 13 | Encephalitis (HP:0002383) | 4.16412104 |
| 14 | Meningitis (HP:0001287) | 4.07092264 |
| 15 | Agammaglobulinemia (HP:0004432) | 3.80334559 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.72771088 |
| 17 | Keratoconjunctivitis sicca (HP:0001097) | 3.63999691 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.46864314 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.39856785 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.39856785 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 3.39562552 |
| 22 | Keratoconjunctivitis (HP:0001096) | 3.39549472 |
| 23 | Increased IgE level (HP:0003212) | 3.37387455 |
| 24 | Obstructive lung disease (HP:0006536) | 3.30923051 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.30923051 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.25409032 |
| 27 | Petechiae (HP:0000967) | 3.15901766 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.13691077 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.13691077 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.13691077 |
| 31 | Prolonged bleeding time (HP:0003010) | 3.13381505 |
| 32 | Granulocytopenia (HP:0001913) | 3.13239748 |
| 33 | Recurrent skin infections (HP:0001581) | 3.10340308 |
| 34 | Acute lymphatic leukemia (HP:0006721) | 3.09564075 |
| 35 | Vasculitis (HP:0002633) | 3.06513182 |
| 36 | Recurrent viral infections (HP:0004429) | 2.96562822 |
| 37 | Abnormality of T cells (HP:0002843) | 2.94360220 |
| 38 | Urticaria (HP:0001025) | 2.92476961 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 2.92119325 |
| 40 | T lymphocytopenia (HP:0005403) | 2.91488356 |
| 41 | Leukocytosis (HP:0001974) | 2.87532048 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.86106063 |
| 43 | Severe combined immunodeficiency (HP:0004430) | 2.85539403 |
| 44 | Inflammation of the large intestine (HP:0002037) | 2.81454080 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 2.79248121 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.77218074 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.76611447 |
| 48 | Pustule (HP:0200039) | 2.72871076 |
| 49 | Epistaxis (HP:0000421) | 2.71225530 |
| 50 | Episodic fever (HP:0001954) | 2.69593910 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.69523565 |
| 52 | Arterial thrombosis (HP:0004420) | 2.69191927 |
| 53 | Cellulitis (HP:0100658) | 2.69083154 |
| 54 | Amyloidosis (HP:0011034) | 2.68390786 |
| 55 | Hemoptysis (HP:0002105) | 2.67287951 |
| 56 | Chest pain (HP:0100749) | 2.65874903 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.59478398 |
| 58 | Purpura (HP:0000979) | 2.53111266 |
| 59 | Pulmonary embolism (HP:0002204) | 2.47419291 |
| 60 | Fatigue (HP:0012378) | 2.47145636 |
| 61 | Alveolar cell carcinoma (HP:0006519) | 2.46741153 |
| 62 | Combined immunodeficiency (HP:0005387) | 2.39669475 |
| 63 | Colitis (HP:0002583) | 2.37478719 |
| 64 | Hepatosplenomegaly (HP:0001433) | 2.37475763 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.37241450 |
| 66 | Polygenic inheritance (HP:0010982) | 2.36749820 |
| 67 | Anorexia (HP:0002039) | 2.36308616 |
| 68 | Acute myeloid leukemia (HP:0004808) | 2.35119144 |
| 69 | Gangrene (HP:0100758) | 2.31344058 |
| 70 | Gingival bleeding (HP:0000225) | 2.29682476 |
| 71 | Abnormality of B cell number (HP:0010975) | 2.28280693 |
| 72 | Osteomyelitis (HP:0002754) | 2.27150421 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.26772558 |
| 74 | Acute hepatic failure (HP:0006554) | 2.24903110 |
| 75 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.23712363 |
| 76 | Polyneuropathy (HP:0001271) | 2.22148892 |
| 77 | Abnormality of eosinophils (HP:0001879) | 2.17964641 |
| 78 | Eosinophilia (HP:0001880) | 2.14756390 |
| 79 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.14629280 |
| 80 | Joint swelling (HP:0001386) | 2.13570874 |
| 81 | Vertigo (HP:0002321) | 2.13052544 |
| 82 | Sepsis (HP:0100806) | 2.06829082 |
| 83 | Chronic otitis media (HP:0000389) | 2.05644555 |
| 84 | Increased IgM level (HP:0003496) | 2.04928439 |
| 85 | Glomerulopathy (HP:0100820) | 2.03830256 |
| 86 | Abnormality of the pericardium (HP:0001697) | 2.02117417 |
| 87 | B lymphocytopenia (HP:0010976) | 2.01699972 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 2.01684215 |
| 89 | Gingivitis (HP:0000230) | 2.00599647 |
| 90 | Acne (HP:0001061) | 1.99741719 |
| 91 | Abnormality of the prostate (HP:0008775) | 1.99715074 |
| 92 | Increased serum ferritin (HP:0003281) | 1.98999371 |
| 93 | Vacuolated lymphocytes (HP:0001922) | 1.98567980 |
| 94 | Keratitis (HP:0000491) | 1.96636359 |
| 95 | Lymphopenia (HP:0001888) | 1.96337593 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 1.94987153 |
| 97 | Skin rash (HP:0000988) | 1.94016070 |
| 98 | Increased cerebral lipofuscin (HP:0011813) | 1.91884688 |
| 99 | Amaurosis fugax (HP:0100576) | 1.90080505 |
| 100 | Hypertriglyceridemia (HP:0002155) | 1.89884189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.15252696 |
| 2 | KIT | 3.99562530 |
| 3 | IRAK4 | 3.86572972 |
| 4 | ERN1 | 3.42382132 |
| 5 | RIPK4 | 3.19037377 |
| 6 | GRK6 | 2.75409482 |
| 7 | MAP2K3 | 2.62656155 |
| 8 | FES | 2.46065568 |
| 9 | CSF1R | 2.27975767 |
| 10 | FLT3 | 2.17727841 |
| 11 | TAOK3 | 2.17317165 |
| 12 | TXK | 2.14231196 |
| 13 | SYK | 2.12274639 |
| 14 | AKT3 | 2.07241281 |
| 15 | CDK19 | 1.97424683 |
| 16 | PRPF4B | 1.92017321 |
| 17 | JAK3 | 1.89334975 |
| 18 | BTK | 1.86047321 |
| 19 | MARK3 | 1.85222731 |
| 20 | TAF1 | 1.74791991 |
| 21 | TYK2 | 1.74375057 |
| 22 | TNK2 | 1.71731808 |
| 23 | ZAP70 | 1.71591421 |
| 24 | BLK | 1.63917160 |
| 25 | PIK3CG | 1.58437500 |
| 26 | CSK | 1.56202477 |
| 27 | TESK2 | 1.51442184 |
| 28 | LCK | 1.47078411 |
| 29 | MAP3K13 | 1.46673530 |
| 30 | HCK | 1.45349675 |
| 31 | MATK | 1.38590149 |
| 32 | MAP3K14 | 1.34533898 |
| 33 | SCYL2 | 1.32270553 |
| 34 | LYN | 1.28688871 |
| 35 | BCKDK | 1.27116092 |
| 36 | ITK | 1.24447987 |
| 37 | TEC | 1.23857573 |
| 38 | MAP3K11 | 1.22323214 |
| 39 | GRK7 | 1.18721464 |
| 40 | TBK1 | 1.18482971 |
| 41 | IKBKE | 1.18205630 |
| 42 | BMPR2 | 1.14225149 |
| 43 | MAP4K2 | 1.08947397 |
| 44 | PIM1 | 1.01243948 |
| 45 | ILK | 0.97944587 |
| 46 | STK10 | 0.97191621 |
| 47 | IKBKB | 0.95259618 |
| 48 | PDK1 | 0.90997468 |
| 49 | JAK1 | 0.90776119 |
| 50 | EPHB1 | 0.89759424 |
| 51 | BRAF | 0.85728971 |
| 52 | MAP2K6 | 0.84215756 |
| 53 | JAK2 | 0.83835873 |
| 54 | MOS | 0.83748686 |
| 55 | TGFBR2 | 0.76179467 |
| 56 | MAPK12 | 0.75702510 |
| 57 | LRRK2 | 0.75133244 |
| 58 | HIPK2 | 0.73480979 |
| 59 | PRKCQ | 0.71020713 |
| 60 | KDR | 0.70238411 |
| 61 | FGR | 0.68495141 |
| 62 | SGK2 | 0.65502896 |
| 63 | RPS6KA4 | 0.59939584 |
| 64 | CDK4 | 0.57866686 |
| 65 | TAOK2 | 0.57079565 |
| 66 | PDPK1 | 0.56339016 |
| 67 | ACVR1B | 0.53843242 |
| 68 | DAPK1 | 0.52378566 |
| 69 | RPS6KL1 | 0.49577642 |
| 70 | RPS6KC1 | 0.49577642 |
| 71 | SGK3 | 0.48620267 |
| 72 | ALK | 0.48327456 |
| 73 | NME2 | 0.48269232 |
| 74 | MAP3K3 | 0.48172528 |
| 75 | PRKCH | 0.47165383 |
| 76 | SIK3 | 0.44990779 |
| 77 | KSR1 | 0.44669665 |
| 78 | RPS6KA6 | 0.43730928 |
| 79 | MAP3K1 | 0.43384055 |
| 80 | YES1 | 0.42000858 |
| 81 | TAOK1 | 0.41474443 |
| 82 | FYN | 0.41274967 |
| 83 | MAP2K2 | 0.41046172 |
| 84 | MAPKAPK2 | 0.40296645 |
| 85 | PTK2B | 0.38321448 |
| 86 | IRAK1 | 0.36600385 |
| 87 | CDK6 | 0.35742723 |
| 88 | MAPK13 | 0.34313137 |
| 89 | STK11 | 0.33159513 |
| 90 | PRKD2 | 0.31520332 |
| 91 | PRKCD | 0.31468511 |
| 92 | MAP2K4 | 0.31068543 |
| 93 | MAPK4 | 0.29458272 |
| 94 | MAPK3 | 0.28713898 |
| 95 | MAPK11 | 0.28700738 |
| 96 | ABL1 | 0.28031646 |
| 97 | EGFR | 0.27616359 |
| 98 | MAPK7 | 0.27229737 |
| 99 | DYRK1B | 0.26582511 |
| 100 | FGFR3 | 0.25840008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.49130099 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.34235897 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.23555903 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.96627289 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.94307233 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.55510927 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.54658689 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.52243960 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.51771156 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.48884199 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.38637759 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.31491296 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.26086015 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 2.16741264 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03073708 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 2.02640532 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95966051 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.80473913 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.76524704 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.72752618 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66760279 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.65716740 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.60091087 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53251018 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.53240263 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49699162 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45900484 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45178025 |
| 29 | Platelet activation_Homo sapiens_hsa04611 | 1.44065905 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.43517926 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.40348155 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37278019 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33334332 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32831980 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31089250 |
| 36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30186401 |
| 37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.28969937 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.28852964 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.07072314 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06029288 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.05543830 |
| 42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02445027 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.01649216 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.01617629 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00743870 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 0.98630096 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96808613 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91500256 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91316460 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89410645 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.83877675 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83813498 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78933292 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 0.74395864 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72288205 |
| 56 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69813747 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68829968 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67980655 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66256707 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.65595419 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64158301 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63809314 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.63382555 |
| 64 | Base excision repair_Homo sapiens_hsa03410 | 0.60858587 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59855298 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.57945483 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56223414 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55925558 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55700601 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54581117 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53608609 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51900151 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49387850 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47085763 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45650512 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44975351 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44566757 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38153175 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36106757 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35950280 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35060322 |
| 82 | Ribosome_Homo sapiens_hsa03010 | 0.34612549 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32589203 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31085299 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30853275 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28418766 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.28239191 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26047737 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.24823819 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23996913 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.23258409 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22031088 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.21621387 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20998776 |
| 95 | Phototransduction_Homo sapiens_hsa04744 | 0.20799496 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.19920439 |
| 97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.19481483 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.19097437 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17683708 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.15481116 |

